340B Drug Pricing Program Reporting

Beginning in April 2024, health care entities that participate as “covered entities” in the federal 340B Drug Pricing Program will be required to annually report data related to their 340B prescription drug purchases and payments to the Minnesota Department of Health (MDH). MDH will synthesize its findings in annual reports to the legislature on the reported data beginning in November 2024. 

This initiative was established by the legislature in 2023 and is codified in Minnesota Statues, section 62J.312, subd. 6. 

This website serves as a means monitor progress, access resources, ask questions, and sign up for our email updates for news and notifications. 

NEW: MDH released a video, Tutorial: Online Portal for 340B Reporting (YouTube) and added content to Frequently Asked Questions (PDF) for upcoming 340B reporting.

Register and Report Online

Reporting entities preparing to submit a report are encouraged to access the online reporting system to register at MN Department of Health Rx. Data submitters may view the Registration Quick-Start Guide (PDF), consult the Registration and Account Management Guide (PDF), or visit the Data Reporting Portal Help page for more resources. 

Reporting Resources

• Form and Manner for 340B Covered Entities (PDF)
• Frequently Asked Questions (PDF)
• Rx Data Reporting Portal
• Tutorial: Online Portal for 340B Reporting (YouTube)

Upcoming Implementation Steps 

• April 1, 2024: Covered entities’ reports are due to MDH